Wellcome Trust

The Wellcome Trust is a UK-headquartered biomedical research foundation, established in 1936 from the estate of pharmaceutical entrepreneur Sir Henry Wellcome, the American-British co-founder of Burroughs Wellcome & Co., with the founding purpose of advancing medical and scientific research. Wellcome's mission is to support science to solve urgent health challenges, and it operates at a scale that places it among the world's largest charitable foundations — endowment of GBP 37.6 billion and charitable expenditure of GBP 1.9 billion in the 2024/25 financial year, up from GBP 1.6 billion in 2023/24. The Trust is currently led by chief executive John-Arne Røttingen, who took office in 2024 succeeding Jeremy Farrar's 2013–2023 tenure, with Julia Gillard serving as Chair. The Trust's programmatic core is biomedical research, open-access publishing, improving research culture, and global health initiatives across Asia and Africa — a portfolio quite distinct from the civil-society / digital-rights register that anchors most of the corpus's funder slice.

Position in the corpus funder slice — health-data-ethics, not civil-society / digital-rights

Wellcome's intersection with the AI-good movement the corpus tracks sits on the health-data-ethics axis, not the broader civil-society / digital-rights axis. The Trust does not appear on any of the published partner rosters of the three pooled vehicles and named coalitions that anchor most of the corpus's European and US funder layer: not the European AI & Society Fund (whose contributing partners include the Charles Stewart Mott Foundation, Luminate, the Mozilla Foundation, the Oak Foundation, Open Society Foundations, and Stiftung Mercator among others), not the Public Interest Technology initiative or Humanity AI coalition (whose participating philanthropies are the Ford Foundation, the Open Society Foundations, the MacArthur Foundation, the Mozilla Foundation, the Omidyar Network, the Kapor Foundation, the Heising-Simons Foundation, the Packard Foundation, the Democracy Fund, and the Wallace Global Fund), and not the Civitates pooled vehicle. Wellcome's AI route is upstream of that organising layer: grants to academic and research institutions investigating the ethical, social, and political dimensions of AI in health, alongside Wellcome-published policy outputs in the same area — Wellcome's 2018 report "Ethical, Social and Political Challenges of Artificial Intelligence in Health", on which the University of Edinburgh's Claudia Pagliari served as advisor, is one concrete trace of that register — and major-initiative funding for health-data-research infrastructure that includes data-ethics governance commitments.

Within the corpus's UK funder cluster, that positioning makes Wellcome a register peer of the Nuffield Foundation — both UK, both research-funder rather than activist-funder — but with the AI-good route running through health and biomedicine rather than through the data-governance and social-wellbeing remit Nuffield occupies. It is a distinct register from the Sigrid Rausing Trust, whose UK family-foundation grant-making targets human rights and women's rights organisations with a much smaller direct overlap with health philanthropy. The three together — Nuffield, Sigrid Rausing, Wellcome — span the UK foundation contribution to the AI-good landscape: Nuffield as the data-governance and public-deliberation funder, Sigrid Rausing as the civil-liberties and women's-rights funder, and Wellcome as the health-and-biomedical-ethics funder.

Ada Lovelace Institute — founding partner, not primary funder

Wellcome was one of the eight collaborating organisations named as founding partners when the Nuffield Foundation announced the establishment of the Ada Lovelace Institute in March 2018. The financial primary funder of the Institute is the Nuffield Foundation, with GBP 5 million committed over five years to establish it; Wellcome's role was as a collaborating founding partner — convening, advisory, and the lending of biomedical-ethics expertise — alongside the Alan Turing Institute, the Royal Society, the British Academy, the Royal Statistical Society, techUK, the Nuffield Council on Bioethics, and Omidyar Network's Governance and Citizen Engagement Initiative. The Ada Lovelace Institute's own About page names an eight-organisation founding-partner roster that differs from the Nuffield announcement on one slot — Luminate appears in place of Omidyar Network's Governance and Citizen Engagement Initiative. This distinction matters for the funder slice: while several published descriptions of the Institute group the founding partners together, the Ada Lovelace Institute's corpus entry carries only fund-nuffield-foundation on its funders[] list, consistent with Wellcome's role as collaborator rather than direct grantor of the Institute's core operating funding. The corpus does not record Wellcome in org-ada-lovelace-institute.funders[].

EVAH and the in-house AI-in-health programme

Beyond grant-making, Wellcome participates in the EVAH (Evidence for AI in Health) initiative as one of three philanthropic partners alongside the Gates Foundation and the Novo Nordisk Foundation — a joint USD 60 million commitment delivered with J-PAL and APHRC as implementation partners, focused on evaluations of AI clinical decision-support tools designed for frontline health workers in primary and community care settings across sub-Saharan Africa, South Asia, and Southeast Asia. EVAH sits inside Wellcome's broader research-strategy bet that the next decade of biomedical research will be shaped by data, AI, and computational methods, and that the ethics, governance, and civic-trust infrastructure for that shift needs deliberate funder-led investment. The Wellcome Centre for Ethics and Humanities at Oxford is the institutional home for much of that work, with a remit Wellcome describes as rethinking bioethics to recognise the importance of data, genomics, neuroscience, and global interconnectivity. These programmes are upstream of the on-the-ground civil-society organising the corpus tracks — they fund the academic ethics infrastructure that organisations like the Ada Lovelace Institute and the Nuffield Council on Bioethics then translate into public-deliberation and policy-engagement work — but they are the route through which Wellcome's GBP 1.9 billion annual charitable spend touches the AI-good landscape at all.